| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |